Delivery Order SPE2DB22D3011-SPE2DB25FQ1UK

Award Date 7/16/25
Potential Completion Date 7/17/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,701.30 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 18, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,047.03 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2025, with a completion date of February 25, 2025. This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $18,395.16, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 29, 2024. The contract is not designated as a set-aside and appears to be part of a larger...
The federal contract award is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. The $5,455.45 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 11, 2025 and does not include a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
This federal contract award is for the delivery of WEGOVY 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $5,024.56, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 13, 2024, with a completion date of March 14, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $5,541.48 and an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $7,416.27 firm fixed-price delivery order contract was awarded on July 11, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of July 14, 2025. The contract is not set-aside and allows for the supply of prescription medications, medical devices, and other healthcare-related...
This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $15,983.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 11, 2024, with a completion date of December 12, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,770.74 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,228.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FQ1UK
    Delivery Order

The federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $11,283.17 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with an ultimate completion date of July 17, 2025. This delivery order contract is not a set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which runs through December 2026. This comprehensive global pharmaceutical support vehicle enables Amerisourcebergen to supply a wide range of medical products and supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military and other government healthcare programs.

Generated 10/15/25, 9:55 AM